Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
SANUWAVE Health received a deficiency notice from Nasdaq because its Market Value of Listed Securities (MVLS) fell below the $50 million minimum requirement for 30 consecutive business days. The company has 180 calendar days, or until March 22, 2027, to regain compliance by maintaining an MVLS of at least $50 million for 10 consecutive business days.
Quantum Cyber M&A Deal with Arcade Realty LLC and Arcade Technology LLC
Quantum Cyber N.V. filed an amendment to its previous 8-K to provide required historical and pro forma financial statements following its acquisition of real property from Arcade Realty LLC and business assets from Arcade Technology LLC. The acquired business provides precision metal stamping, tool design, and manufacturing services in Bridgeport, Connecticut.
Golub Capital Private Income Fund I Capital Raise of $2.34M
Golub Capital Private Income Fund I raised approximately $2.34 million through the unregistered sale of 96,269 common shares to investors as of September 1, 2026. The shares were sold at a price of $24.30 per share, which was the Fund's net asset value (NAV) as of August 31, 2026. The filing also disclosed a monthly distribution of $0.1667 per share and provided a portfolio update showing $438 million in total fair value across 171 portfolio companies.
Mara Holdings Signs $600M M&A Deal with Hif USA LLC
MARA Holdings, Inc. entered into an amendment regarding its acquisition of MAT 1177 LLC, which holds rights to a 2,000-megawatt power capacity site in Texas. The amendment restructures milestone payments and eliminates a reconveyance provision, while maintaining an aggregate potential purchase price of $600 million. As part of the update, MARA's subsidiary posted a $100 million security deposit with the electric utility company for the site's power capacity.
BlackRock Private Credit Fund reported an unregistered sale of equity securities under Item 3.02. As a private credit fund, this typically represents the issuance of shares to investors through its continuous offering or a private placement.
Medalist Diversified M&A Deal with Overland Park Caliber Collision Property
Medalist Diversified, Inc. filed audited financial statements for the Overland Park Caliber Collision Property for the year ended December 31, 2025, and unaudited statements for the six months ended June 30, 2026. This filing provides required financial disclosures following the acquisition of the property to comply with SEC reporting regulations. The statements focus on revenues and certain operating expenses as part of the company's real estate investment portfolio.
WhiteHawk Minerals Signs $105M M&A Deal with Three Rivers Royalty II
WhiteHawk Minerals Corp. completed the acquisition of mineral and royalty interests in the Marcellus and Haynesville shale basins for an aggregate purchase price of $105.0 million. The transaction, referred to as the SJM II Acquisition, was funded through a combination of a $50 million Series E Preferred Stock offering, a previous common stock private placement, and cash on hand.
Value
$105M
Counterparty
Three Rivers Royalty II, LLC and Cypress Mineral Partners, LLC
Apollo Infrastructure Company LLC issued and sold unregistered Series I and Series II shares to third-party investors for approximately $68.1 million in aggregate consideration. The company also reported a total Transactional Net Asset Value of approximately $2.14 billion as of August 31, 2026.
Silver Point Private Credit Fund Capital Raise of $24.3M
Silver Point Private Credit Fund issued and sold 902,356 unregistered common shares for total proceeds of approximately $24.3 million. The shares were sold at a price of $26.94 per share to investors under subscription agreements. Additionally, the fund declared a monthly dividend of $0.1575 per share payable in October 2026.
IEH Wins $3.6M Contract from a leading manufacturer of mobile defibrillators
IEH Corporation received $3.6 million in new orders from a leading medical device manufacturer for its Hyperboloid connectors to be used in mobile defibrillators. This contract represents a strategic expansion into the medical market, diversifying the company's revenue beyond its core defense and aerospace business.
Moleculin Biotech announced new preclinical data for its lead drug candidate, Annamycin, showing that its antitumor activity in pancreatic cancer is partially mediated by CD8+ T cell cytotoxicity. The findings, presented at the AACR Conference on Pancreatic Cancer, suggest the drug may turn immunologically 'cold' tumors 'hot,' potentially enabling new combination therapy approaches.
Aeternum Health M&A Deal with American Renaissance Resources LLC
Aeternum Health acquired 100% of the membership interests in American Renaissance Minerals LLC (ARM) from American Renaissance Resources LLC, consolidating a previous 51% joint venture option. ARM holds the rights to acquire the Nkamouna Cobalt-Nickel-Manganese Project in Cameroon, a major critical minerals project. As consideration, Aeternum will issue up to 133,333,333 pre-split shares of common stock or pre-funded warrants in stages based on project milestones.
Tessera Defense & Homeland Security Signs $6.63M M&A Deal with X S.E. Security and Defense Ltd.
Tessera Defense and Homeland Security Inc., through its subsidiary, entered into an option agreement to acquire a 51% controlling interest in RT LTA Systems Ltd., an Israeli manufacturer of tethered aerostat surveillance systems. The purchase price is capped at 51% of a $13 million equity value ($6.63 million) and is subject to a 90-day due diligence period and regulatory approvals from the Israeli Ministry of Defense.
Nauticus Robotics has entered into a non-binding letter of intent for a private placement equity investment of up to $50 million from a strategic investor. The capital is intended to support the company's short- and long-term commercial objectives for its autonomous subsea robotic systems. The proposed transaction remains subject to due diligence and definitive agreements, and could potentially result in a change of control.
Fathom Holdings Signs $130M M&A Deal with Neighborhood Intelligence, Inc.
Fathom Holdings and Neighborhood Intelligence (NXH) have agreed to explore a restructured transaction that would replace their previous merger agreement. Under the proposed terms, NXH would contribute its digital asset holdings, including a 38.8% stake in tZERO, to Fathom in exchange for newly issued shares valued at no less than $130 million, resulting in NXH maintaining a controlling interest in Fathom.
Lumen Technologies is voluntarily transferring its stock exchange listing from the New York Stock Exchange (NYSE) to The Nasdaq Stock Market LLC. The common stock (LUMN) and two series of notes are expected to begin trading on Nasdaq on October 6, 2026, following their delisting from the NYSE on October 5, 2026.
Cipher Digital Wins $5.2B Contract from Fluidstack USA II Inc. and a leading AI lab
Cipher Digital entered into a binding commitment with a leading AI lab to extend the lease term of its Barber Lake HPC data center from 10 to 20 years, adding approximately $5.2 billion in incremental contracted revenue. The agreement also includes a cost-reimbursement framework for facility modifications and establishes a phased delivery schedule for data halls starting in Q4 2026.
First Seacoast Bancorp M&A Deal with Cambridge Financial Group, Inc.
First Seacoast Bancorp, Inc. announced it has received the final regulatory approvals and waivers required to complete its merger with Cambridge Financial Group, Inc. The transaction, which includes the merger of First Seacoast Bank into Cambridge Savings Bank, is expected to close on October 1, 2026.
Blue Acquisition M&A Deal with Blockfusion USA, Inc.
Blue Acquisition Corp. (BACC) provided an updated investor presentation regarding its pending business combination with Blockfusion USA, Inc. The transaction, originally announced in November 2025, will result in both companies becoming subsidiaries of a new publicly traded entity, Blockfusion Digital Infrastructure, Inc. (Pubco).
C4 Therapeutics presented new biomarker data from its Phase 1 trial of cemsidomide with dexamethasone and preliminary Phase 1b data for cemsidomide combined with elranatamab at the 23rd International Myeloma Society Annual Meeting. The data demonstrated that cemsidomide drives T-cell activation and prevents T-cell exhaustion, supporting its potential as a combination partner for immune-based therapies in relapsed/refractory multiple myeloma. Additionally, the 75 µg dose level in the Phase 1b trial was declared safe, allowing the study to advance to dose expansion and escalation cohorts.
Atlas Energy Solutions entered into purchase commitments for 283 MW of incremental Caterpillar natural gas generation equipment and an additional 328 MW of generating capacity for 2027 deliveries. These equipment purchases are backed by cost reimbursement agreements with a leading frontier AI lab to support the deployment of power infrastructure for specific data center projects.
Quanome Technologies entered into an $18.8 million purchase agreement for NVIDIA GPU-powered computing infrastructure to build its first U.S. AI infrastructure hub. The project, managed through its subsidiary XDT, aims to launch an AI cloud business providing managed access to computing capacity starting in Q4 2026.
Atlas Energy Solutions Capacity Expansion: $614M Investment
Atlas Energy Solutions entered into two purchase agreements with Wyoming Machinery Company totaling $613.5 million for power generation and balance-of-plant equipment. The equipment will support a 328 MW power generation project for a leading frontier AI lab off-taker, with shipments scheduled between 2027 and 2028.
Glucotrack, Inc. entered into a securities purchase agreement for a registered direct offering of 169,388 shares of common stock and pre-funded warrants for 1,350,220 shares, raising approximately $3.1 million in gross proceeds. The offering was priced at $2.04 per share (or $2.039 per pre-funded warrant) and is intended to fund debt repayment and general working capital.
Acadia Pharmaceuticals announced Phase 3 enabling topline results from the Phase 2 portion of its RADIANT trial evaluating remlifanserin for Alzheimer’s disease psychosis (ADP). While the 60 mg dose narrowly missed the primary endpoint (p=0.0603), it showed nominal significance on a key secondary endpoint and a favorable safety profile, leading the company to continue its Phase 3 program with the 60 mg dose.
UY Scuti Acquisition Signs $920M M&A Deal with Isdera Group Limited
UY Scuti Acquisition Corp. entered into a joinder agreement and a first amendment to its existing merger agreement with Isdera Group Limited. The amendment revises the 'Company Net Value' of the target to $920 million and adds newly formed entities Isdera Inc and Isdera Technology Limited as parties to the transaction.
Iridium Communications M&A Deal with Rocket Lab Corporation
Iridium Communications stockholders have approved the company's acquisition by Rocket Lab Corporation, with approximately 99.6% of votes cast in favor of the merger. Under the deal terms, Iridium stockholders will receive $27.00 in cash plus Rocket Lab common stock for a total notional value of $54.00 per share. The transaction is expected to close in mid-2027, pending final regulatory approvals.
Select Water Solutions Signs $700M M&A Deal with Pilot Water Solutions LLC
Select Water Solutions has entered into a definitive agreement to acquire Pilot Water Solutions LLC for $700 million, consisting of $600 million in cash and $100 million in Class A common stock. The acquisition significantly expands Select's Delaware Basin water midstream infrastructure, adding 2.7 million barrels per day of disposal capacity and over 700 miles of pipeline. The deal is expected to close in Q4 2026 and contribute an estimated $120-$130 million in 2027 EBITDA.
LGAM Private Credit LLC sold approximately 55,206 common units for aggregate proceeds of $1.1 million at a price of $19.46 per unit. The unregistered sale was conducted via subscription agreements with unitholders under Regulation S exemptions. The company also declared a regular distribution of $0.1378 per unit and provided an update on its $645.3 million investment portfolio.
Patriot National Bancorp entered into a securities purchase agreement to raise approximately $5.5 million through a registered direct offering of 4,782,608 shares of voting common stock and 956,522 five-year warrants. The common stock was priced at $1.15 per share, and the company intends to use the proceeds to invest capital into its subsidiary, Patriot Bank NA, and for general corporate purposes.